Thus, these six novel lncRNAs may begin their function by activating genes in the ‘Renal cell carcinoma pathway.’ In addition to the ‘Renal cell carcinoma pathway,’ by modulating the ‘Wnt signaling pathway,’ the lncRNAs CCAT2 and Kindlin‐2 appear to promote clear cell renal cell carcinoma progression [50, 51]. This evidence concerns the gene CCAT2 and renal cell carcinoma.